On the basis of the WHO 2016 classification of CNS tumors, 946 primary DGs were classified into 5 molecular subtypes through the integrated diagnosis of histological features and the status of IDH1/2 mutation and chromosome 1p/19q deletion (Table 2). Here, IDH1 is linked to central nervous system neoplasm.